Educational needs in neuro-oncology: Insights from the European Society for Medical Oncology Central Nervous System Faculty Survey
Authors:
- Oriol MirallasOMOriol Mirallas
- Giulia CerrettiGCGiulia Cerretti
- Anna Sophie BerghoffABAnna Sophie Berghoff
- Dieta BrandsmaDBDieta Brandsma
- Filip De VosFVFilip De Vos
- Julia FurtnerJulia Furtner
- Norbert GalldiksNGNorbert Galldiks
- Giuseppe LombardiGLGiuseppe Lombardi
- Slavka LukacovaSLSlavka Lukacova
- Evangelia RazisEREvangelia Razis
- Ghazaleh TabatabaiGhazaleh Tabatabai
- Emilie Le RhunEREmilie Le Rhun
Open Access
- 12 January 2026
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1) , vdag097
Abstract
Background: Primary central nervous system (CNS) tumors are rare malignancies with limited treatment options, resulting in high mortality. Unlike other solid tumors, CNS tumors present unique challenges that impact the health-related quality of life (HRQoL) of patients and caregivers. Effective management requires balancing oncologic treatment with the control of neurocognitive deficits, epilepsy, and other neurological symptoms. Methods: The European Society for Medical Oncology (ESMO) CNS Faculty conducted a consensus process to identify the most pressing educational priorities for physicians managing CNS malignancies. This process involved structured data collection and expert input to determine critical areas for disease-specific education and training. Results: The consensus process highlighted key educational gaps in managing CNS tumors, emphasizing the need for a multidisciplinary approach to optimize therapeutic strategies, improve survival outcomes, enhance HRQoL during treatment and survivorship, and facilitate access to emerging therapies. Physicians reported that comprehensive, disease-specific education is essential to address these challenges effectively. Conclusion: CNS tumors require targeted educational initiatives to equip healthcare providers with the knowledge and skills necessary for optimal patient care. The ESMO CNS Faculty consensus underscores the importance of structured, disease-specific training to improve outcomes, support HRQoL, and advance oncology education in the management of CNS malignancies.Keywords
This publication has 10 references indexed in Scilit:
- Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection—Update 1Neuro-Oncology, 2024
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017–2021Neuro-Oncology, 2024
- Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals’ perspectivesNeuro-Oncology Practice, 2024
- International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of diseaseHeliyon, 2023
- Can neuro-oncology teaching contribute to educate medical doctors better? A reflection on the value of neuro-oncology for student teachingChinese Neurosurgical Journal, 2022
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summaryNeuro-Oncology, 2021
- Delivering Equitable Care to Underserved Neuro-oncology PopulationsAmerican Society of Clinical Oncology Educational Book, 2021
- Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology membersNeuro-Oncology Practice, 2021
- EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodNature Reviews Clinical Oncology, 2020
- Palliative care education in U.S. adult neuro-oncology fellowship programsJournal of Neuro-Oncology, 2018